Condition

Metastatic Malignant Neoplasm clinical trials and research

As of November 12, 2026, Find a Trial lists 3 Metastatic Malignant Neoplasm clinical trials that are recruiting, at sites in 2 countries (most in United States (3), South Korea (1)). By phase: Phase 1 (2), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.

Newest Metastatic Malignant Neoplasm clinical trials

StudyPhaseWhereStatusRegistered
NPX372 in selected solid tumors Phase 1 La Jolla, California and 5 other locations Recruiting May 4, 2026
NPX887 treatment for solid tumors expressing B7-H7/HHLA2 Phase 1 Baltimore, Maryland and 7 other locations Recruiting Feb 5, 2024
Comparing single-fraction SBRT to standard radiation for metastatic cancer treatment Phase 2 Buffalo, New York and 2 other locations Recruiting Aug 28, 2019

All recruiting trials (3)

Quick answers

How many Metastatic Malignant Neoplasm clinical trials are recruiting right now?

3, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 2 countries. The most sites are in United States (3 trials), South Korea (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1: 2, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →

Last reviewed 2026-11-12 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.